GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
PRDM14
|
ENSG00000147596.3 | PR/SET domain 14 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PRDM14 | hg19_v2_chr8_-_70983506_70983562 | -0.03 | 6.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_21492251 | 10.03 |
ENST00000554398.1
|
NDRG2
|
NDRG family member 2 |
chr14_-_21492113 | 9.58 |
ENST00000554094.1
|
NDRG2
|
NDRG family member 2 |
chr11_-_62474803 | 6.50 |
ENST00000533982.1
ENST00000360796.5 |
BSCL2
|
Berardinelli-Seip congenital lipodystrophy 2 (seipin) |
chr11_+_62475130 | 6.05 |
ENST00000294117.5
|
GNG3
|
guanine nucleotide binding protein (G protein), gamma 3 |
chr12_-_49351303 | 5.31 |
ENST00000256682.4
|
ARF3
|
ADP-ribosylation factor 3 |
chr20_-_3154162 | 5.04 |
ENST00000360342.3
|
LZTS3
|
Homo sapiens leucine zipper, putative tumor suppressor family member 3 (LZTS3), mRNA. |
chr12_-_49351228 | 5.02 |
ENST00000541959.1
ENST00000447318.2 |
ARF3
|
ADP-ribosylation factor 3 |
chr17_-_19651654 | 4.54 |
ENST00000395555.3
|
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1 |
chr1_+_36621529 | 4.14 |
ENST00000316156.4
|
MAP7D1
|
MAP7 domain containing 1 |
chr1_+_50571949 | 4.11 |
ENST00000357083.4
|
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4 |
chr17_-_19651668 | 4.00 |
ENST00000494157.2
ENST00000225740.6 |
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1 |
chrX_+_51636629 | 3.56 |
ENST00000375722.1
ENST00000326587.7 ENST00000375695.2 |
MAGED1
|
melanoma antigen family D, 1 |
chr7_-_124405681 | 3.43 |
ENST00000303921.2
|
GPR37
|
G protein-coupled receptor 37 (endothelin receptor type B-like) |
chr5_-_16936340 | 2.88 |
ENST00000507288.1
ENST00000513610.1 |
MYO10
|
myosin X |
chr22_+_23241661 | 2.85 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
chr11_-_65624415 | 2.57 |
ENST00000524553.1
ENST00000527344.1 |
CFL1
|
cofilin 1 (non-muscle) |
chr12_-_49351148 | 2.28 |
ENST00000398092.4
ENST00000539611.1 |
RP11-302B13.5
ARF3
|
ADP-ribosylation factor 3 ADP-ribosylation factor 3 |
chr1_+_39796810 | 1.98 |
ENST00000289893.4
|
MACF1
|
microtubule-actin crosslinking factor 1 |
chr3_-_47517302 | 1.66 |
ENST00000441517.2
ENST00000545718.1 |
SCAP
|
SREBF chaperone |
chr8_-_102216925 | 1.56 |
ENST00000517844.1
|
ZNF706
|
zinc finger protein 706 |
chr19_+_39109735 | 1.55 |
ENST00000593149.1
ENST00000248342.4 ENST00000538434.1 ENST00000588934.1 ENST00000545173.2 ENST00000589307.1 ENST00000586513.1 ENST00000591409.1 ENST00000592558.1 |
EIF3K
|
eukaryotic translation initiation factor 3, subunit K |
chr17_-_17485731 | 1.37 |
ENST00000395783.1
|
PEMT
|
phosphatidylethanolamine N-methyltransferase |
chr11_+_64879317 | 1.36 |
ENST00000526809.1
ENST00000279263.7 ENST00000524986.1 ENST00000534371.1 ENST00000540748.1 ENST00000525385.1 ENST00000345348.5 ENST00000531321.1 ENST00000529414.1 ENST00000526085.1 ENST00000530750.1 |
TM7SF2
|
transmembrane 7 superfamily member 2 |
chr1_+_65730385 | 1.32 |
ENST00000263441.7
ENST00000395325.3 |
DNAJC6
|
DnaJ (Hsp40) homolog, subfamily C, member 6 |
chr9_+_132597722 | 1.25 |
ENST00000372429.3
ENST00000315480.4 ENST00000358355.1 |
USP20
|
ubiquitin specific peptidase 20 |
chr12_-_52967600 | 1.15 |
ENST00000549343.1
ENST00000305620.2 |
KRT74
|
keratin 74 |
chr12_+_121647962 | 1.04 |
ENST00000542067.1
|
P2RX4
|
purinergic receptor P2X, ligand-gated ion channel, 4 |
chr7_-_140714739 | 1.03 |
ENST00000467334.1
ENST00000324787.5 |
MRPS33
|
mitochondrial ribosomal protein S33 |
chr10_+_12171636 | 1.03 |
ENST00000379051.1
ENST00000379033.3 ENST00000441368.1 ENST00000298428.9 ENST00000304267.8 |
SEC61A2
|
Sec61 alpha 2 subunit (S. cerevisiae) |
chr10_+_12171721 | 0.99 |
ENST00000379020.4
ENST00000379017.3 |
SEC61A2
|
Sec61 alpha 2 subunit (S. cerevisiae) |
chr3_+_10289707 | 0.96 |
ENST00000287652.4
|
TATDN2
|
TatD DNase domain containing 2 |
chr5_-_24645078 | 0.94 |
ENST00000264463.4
|
CDH10
|
cadherin 10, type 2 (T2-cadherin) |
chr6_-_46048116 | 0.87 |
ENST00000185206.6
|
CLIC5
|
chloride intracellular channel 5 |
chr12_+_121647868 | 0.73 |
ENST00000359949.7
ENST00000541532.1 ENST00000543171.1 ENST00000538701.1 |
P2RX4
|
purinergic receptor P2X, ligand-gated ion channel, 4 |
chr9_+_87283430 | 0.69 |
ENST00000376214.1
ENST00000376213.1 |
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2 |
chr1_-_31845914 | 0.69 |
ENST00000373713.2
|
FABP3
|
fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) |
chr7_-_140714430 | 0.66 |
ENST00000393008.3
|
MRPS33
|
mitochondrial ribosomal protein S33 |
chr12_+_3600356 | 0.60 |
ENST00000382622.3
|
PRMT8
|
protein arginine methyltransferase 8 |
chr3_+_155838337 | 0.58 |
ENST00000490337.1
ENST00000389636.5 |
KCNAB1
|
potassium voltage-gated channel, shaker-related subfamily, beta member 1 |
chr2_-_228244013 | 0.57 |
ENST00000304568.3
|
TM4SF20
|
transmembrane 4 L six family member 20 |
chr16_-_55866997 | 0.53 |
ENST00000360526.3
ENST00000361503.4 |
CES1
|
carboxylesterase 1 |
chr11_-_46615498 | 0.45 |
ENST00000533727.1
ENST00000534300.1 ENST00000528950.1 ENST00000526606.1 |
AMBRA1
|
autophagy/beclin-1 regulator 1 |
chr3_-_155394152 | 0.39 |
ENST00000494598.1
|
PLCH1
|
phospholipase C, eta 1 |
chr19_+_49838653 | 0.31 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
chr11_+_85956182 | 0.29 |
ENST00000327320.4
ENST00000351625.6 ENST00000534595.1 |
EED
|
embryonic ectoderm development |
chr17_+_75450075 | 0.29 |
ENST00000592951.1
|
SEPT9
|
septin 9 |
chr1_-_27216729 | 0.27 |
ENST00000431781.2
ENST00000374135.4 |
GPN2
|
GPN-loop GTPase 2 |
chr14_+_22993296 | 0.27 |
ENST00000390517.1
|
TRAJ20
|
T cell receptor alpha joining 20 |
chr2_-_69098566 | 0.21 |
ENST00000295379.1
|
BMP10
|
bone morphogenetic protein 10 |
chr12_-_76742183 | 0.19 |
ENST00000393262.3
|
BBS10
|
Bardet-Biedl syndrome 10 |
chr6_+_72926145 | 0.18 |
ENST00000425662.2
ENST00000453976.2 |
RIMS1
|
regulating synaptic membrane exocytosis 1 |
chr20_-_48770174 | 0.18 |
ENST00000341698.2
|
TMEM189-UBE2V1
|
TMEM189-UBE2V1 readthrough |
chr7_+_39989611 | 0.13 |
ENST00000181839.4
|
CDK13
|
cyclin-dependent kinase 13 |
chr19_-_49314269 | 0.12 |
ENST00000545387.2
ENST00000316273.6 ENST00000402551.1 ENST00000598162.1 ENST00000599246.1 |
BCAT2
|
branched chain amino-acid transaminase 2, mitochondrial |
chr3_-_155394099 | 0.03 |
ENST00000414191.1
|
PLCH1
|
phospholipase C, eta 1 |
chr19_-_53757941 | 0.03 |
ENST00000594517.1
ENST00000601413.1 ENST00000594681.1 |
ZNF677
|
zinc finger protein 677 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 19.6 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.5 | 2.6 | GO:0051510 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) regulation of barbed-end actin filament capping(GO:2000812) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.3 | 3.4 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.3 | 1.7 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.3 | 6.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 0.7 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.2 | 1.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 1.6 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 1.3 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.1 | 1.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 3.6 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.7 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.1 | 12.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 6.0 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 0.9 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 8.5 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.1 | 0.3 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 0.6 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 2.0 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.5 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.2 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.0 | 1.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.6 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
0.0 | 2.9 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 1.1 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 1.7 | GO:0070126 | mitochondrial translational elongation(GO:0070125) mitochondrial translational termination(GO:0070126) |
0.0 | 1.4 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 1.0 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.4 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.2 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.0 | 0.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 6.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 22.2 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 1.8 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.6 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 1.7 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 7.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.1 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.0 | 0.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.3 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 1.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 1.1 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 6.9 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 1.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 14.6 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 1.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 4.1 | GO:0005819 | spindle(GO:0005819) |
0.0 | 3.4 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.9 | GO:0034707 | chloride channel complex(GO:0034707) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 8.5 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.5 | 1.4 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.5 | 1.4 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.3 | 6.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.3 | 2.9 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.2 | 0.7 | GO:0070538 | oleic acid binding(GO:0070538) |
0.2 | 0.6 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.2 | 1.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 1.8 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.4 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.1 | 0.7 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.1 | 4.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 1.0 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.5 | GO:0004771 | sterol esterase activity(GO:0004771) methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.1 | 3.6 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 3.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 12.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 1.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.6 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 2.6 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.0 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 1.2 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 1.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 15.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 19.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 2.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 4.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 12.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.3 | 6.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.3 | 3.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 2.6 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 2.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 1.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 1.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 2.0 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |